Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Aug 31, 2025 | (FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Sep 30, 2020 | (Q6)Mar 31, 2020 | (FY)Sep 30, 2019 | (Q6)Mar 31, 2019 | (FY)Sep 30, 2018 | (Q6)Mar 31, 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---38.9M | -91.18%1.12M | 122.49%12.69M | ---56.42M | -251.56%-186.37M | -225.65%-149.86M | -1,428.15%-53.01M | -329.11%-46.02M | -104.55%-3.47M | -56.77%20.09M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---940K | 87.38%-1.37M | 67.48%-10.84M | ---33.33M | 4.00%-43.25M | -12.49%-24.95M | 0.98%-45.05M | 2.84%-22.18M | -2.14%-45.49M | -3.35%-22.83M |
| Impairment and provisions: | --1.19M | 54.73%-10.51M | -28,923.75%-23.22M | ---80K | 663.02%69.6M | 23.48%10.66M | 108.25%9.12M | --8.64M | 249.24%4.38M | ---- |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | 40.14%-4.14M | ---6.92M | 346.75%11.62M | -123.28%-698.5K | --2.6M | --3M | ---- | ---- |
| -Impairment of trade receivables (reversal) | --2.48M | -542.31%-9.98M | -74.71%2.26M | --8.93M | 4,471.43%13.44M | 674.02%9.81M | --294K | --1.27M | ---- | ---- |
| -Impairment of goodwill | ---- | ---- | ---- | ---- | -54.70%2.16M | -54.70%2.15M | 103.95%4.76M | --4.76M | --2.33M | ---- |
| -Other impairments and provisions | ---1.3M | 97.52%-529K | -920.86%-21.34M | ---2.09M | 2,783.54%42.39M | -53.97%-598.19K | -28.22%1.47M | ---388.5K | 63.27%2.05M | ---- |
| Revaluation surplus: | ---490K | -198.06%-1.41M | --1.44M | ---- | -200.00%-335K | ---- | --335K | ---- | ---- | ---- |
| -Fair value of investment properties (increase) | ---490K | -198.06%-1.41M | --1.44M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Derivative financial instruments fair value (increase) | ---- | ---- | ---- | ---- | -200.00%-335K | ---- | --335K | ---- | ---- | ---- |
| Asset sale loss (gain): | ---514K | -456.95%-10.68M | -91.16%2.99M | --33.86M | -423.89%-1.29M | -1,030.01%-131.86K | 77.82%-247K | ---11.67K | -174.48%-1.11M | ---- |
| -Loss (gain) from sale of subsidiary company | ---496K | ---10.05M | ---- | --25.68M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---18K | -121.06%-630K | -63.39%2.99M | --8.17M | -208.91%-763K | -1,030.01%-131.86K | 77.82%-247K | ---11.67K | -174.48%-1.11M | ---- |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---531K | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | --614K | -52.49%667K | -72.61%1.4M | --5.13M | 2.61%10.84M | 2.56%5.36M | -36.38%10.56M | -43.87%5.23M | 0.37%16.6M | 8.03%9.31M |
| -Amortization of intangible assets | --164K | 2.88%286K | -87.99%278K | --2.31M | -55.45%776K | -61.73%260.47K | -75.79%1.74M | -85.43%680.61K | -15.67%7.2M | -6.32%4.67M |
| Financial expense | --1M | -30.30%2.7M | -73.70%3.88M | --14.73M | 0.21%19.02M | 26.36%11.8M | 1.89%18.99M | -14.08%9.34M | -1.16%18.63M | 10.69%10.87M |
| Unrealized exchange loss (gain) | --75K | 450.00%55K | -94.38%10K | --178K | 162.59%460K | 31,625.25%778.99K | -293.68%-735K | -100.21%-2.47K | -61.77%379.5K | --1.15M |
| Special items | --3.14M | -5,220.29%-3.53M | 100.15%69K | ---46.11M | ---- | 617.63%5.7M | 427.44%994K | --793.99K | --188.46K | ---- |
| Adjustment items | ---- | ---- | ---- | ---- | --93K | ---- | ---- | ---- | ---- | ---- |
| Operating profit before the change of operating capital | ---34.82M | -98.35%-22.97M | 85.89%-11.58M | ---82.05M | -122.26%-131.23M | -218.05%-140.65M | -496.71%-59.04M | -337.89%-44.22M | -113.96%-9.89M | -56.57%18.59M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | ---- | ---- | --7.72M | 100.00%7.72M | --3.86M | 120.00%3.86M | ---- | ---19.3M | ---- |
| Accounts receivable (increase)decrease | ---86.49M | 275.19%17.02M | -107.37%-9.72M | --131.92M | -34.67%61.12M | -229.12%-26.66M | 113.15%93.55M | -9.78%20.65M | 207.01%43.89M | 130.03%22.89M |
| Accounts payable increase (decrease) | --80.59M | 109.31%6.4M | -14.29%-68.75M | ---60.15M | 595.80%130.69M | 265.03%36.79M | 205.63%18.78M | -72.51%-22.29M | -131.53%-17.78M | -152.72%-12.92M |
| Special items for working capital changes | --41.28M | -99.57%316K | 187.37%73.4M | ---84.01M | 40.77%-63.62M | 1,038.62%154.06M | -767.07%-107.42M | --13.53M | 116.26%16.1M | ---- |
| Cash from business operations | --562K | 104.63%771K | 80.78%-16.64M | ---86.57M | 109.31%4.68M | 184.73%27.4M | -486.17%-50.27M | -213.23%-32.33M | 201.66%13.02M | 420.97%28.55M |
| Other taxs | ---59K | -43.62%1.38M | 419.66%2.44M | ---763K | 118.67%1.81M | 214.46%5.13M | 61.75%-9.71M | 71.61%-4.48M | 3.09%-25.38M | -248.36%-15.78M |
| Interest paid - operating | ---- | ---- | ---- | ---- | ---1.64M | ---- | ---- | ---- | ---- | ---- |
| Net cash from operations | --503K | 115.11%2.15M | 83.74%-14.2M | ---87.34M | 108.09%4.85M | 188.35%32.52M | -385.11%-59.98M | -388.22%-36.81M | 68.29%-12.36M | 195.13%12.77M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | --940K | 24.27%681K | -50.50%548K | --1.11M | -31.52%1.56M | 15.62%784.86K | -5.45%2.28M | -47.87%678.82K | 180.43%2.42M | 412.02%1.3M |
| Restricted cash (increase) decrease | --18.34M | -11.39%-3.78M | 82.01%-3.4M | ---18.88M | 15.39%7.47M | -229.34%-11.99M | 149.90%6.47M | 186.62%9.27M | -813.48%-12.97M | -1,076.05%-10.7M |
| Loan receivable (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---2.8M | ---- | ---- | ---- |
| Decrease in deposits (increase) | --3.69M | -7.27%1.63M | -94.71%1.76M | --33.3M | 24.11%-17.77M | 180.34%9.26M | -921.97%-23.41M | -241.73%-11.52M | 123.67%2.85M | 155.08%8.13M |
| Sale of fixed assets | --18K | 122.00%444K | -80.99%200K | --1.05M | 27.29%905K | ---- | -64.45%711K | --75K | -55.81%2M | ---- |
| Purchase of fixed assets | ---128K | 4.00%-24K | ---25K | ---- | 94.48%-119K | 63.87%-73.7K | 67.43%-2.16M | 91.31%-204K | 6.10%-6.62M | -250.31%-2.35M |
| Selling intangible assets | ---- | ---- | ---- | --77K | --4.47M | ---- | ---- | ---- | ---- | ---- |
| Purchase of intangible assets | ---121K | ---48K | ---- | ---- | ---- | ---- | ---3.31M | ---- | ---- | ---- |
| Sale of subsidiaries | ---- | --5.33M | ---- | --88.66M | ---- | ---- | ---- | ---- | ---- | ---- |
| Recovery of cash from investments | ---- | --5.69M | ---- | --319K | --16.35M | --7.8M | ---- | ---- | ---- | ---- |
| Cash on investment | ---- | ---- | ---- | ---- | ---- | ---- | -17,017.23%-22.42M | ---187.79K | ---130.99K | ---- |
| Other items in the investment business | ---- | ---- | ---- | ---- | ---- | ---- | ---2.89M | ---- | ---- | ---- |
| Adjustment items of investment business | ---- | ---- | ---- | ---- | ---93K | ---- | ---- | ---- | ---- | ---- |
| Net cash from investment operations | --22.73M | 1,187.40%9.93M | -100.86%-913K | --105.64M | 126.89%12.78M | 405.34%5.78M | -281.61%-47.51M | 47.62%-1.89M | 3.41%-12.45M | 69.61%-3.61M |
| Net cash before financing | --23.24M | 179.89%12.07M | -182.58%-15.11M | --18.3M | 116.40%17.63M | 198.96%38.31M | -333.18%-107.49M | -522.66%-38.71M | 52.17%-24.81M | 136.17%9.16M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | -74.76%9.6M | -22.97%38.05M | --49.4M | -48.85%112.74M | -82.07%1.31M | 26.65%220.43M | -59.85%7.3M | 254.86%174.05M | 92.44%18.18M |
| Refund | ---- | 94.22%-2.89M | 15.75%-50M | ---59.34M | 18.68%-158.93M | -89.74%-22.86M | -29.19%-195.43M | 1.14%-12.05M | -235.19%-151.27M | 45.91%-12.19M |
| Issuing shares | --2.3M | --441K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Interest paid - financing | ---822K | 26.41%-2.46M | 77.33%-3.34M | ---14.73M | 8.43%-17.39M | -26.36%-11.8M | -1.89%-18.99M | 14.08%-9.34M | 1.16%-18.63M | -10.69%-10.87M |
| Dividends paid - financing | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---13.31M | ---13.31M |
| Absorb investment income | ---- | ---- | ---- | ---- | ---- | ---- | 58,899,900.00%2.95M | --2.94M | --5 | ---- |
| Other items of the financing business | ---1.5M | -158.99%-16.36M | 215.14%27.73M | --8.8M | 31.00%48.77M | ---- | --37.23M | ---- | ---- | ---- |
| Net cash from financing operations | ---380K | -209.86%-12.09M | 154.63%11M | ---20.14M | -159.14%-21.25M | -127.10%-36.86M | 258.83%35.94M | 34.24%-16.23M | -119.07%-22.63M | 4.55%-24.68M |
| Effect of rate | ---75K | -450.00%-55K | 94.38%-10K | ---178K | -15.00%-460K | -31,625.25%-778.99K | -5.40%-400K | 100.21%2.47K | 61.77%-379.5K | ---1.15M |
| Net Cash | --22.86M | 99.68%-13K | -123.79%-4.11M | ---1.84M | 94.93%-3.63M | 102.63%1.45M | -50.81%-71.55M | -253.86%-54.94M | -171.04%-47.44M | 69.67%-15.53M |
| Begining period cash | --6.5M | -38.56%6.57M | -15.86%10.69M | --12.7M | -81.08%16.79M | -81.41%16.79M | -35.02%88.74M | -33.89%90.28M | 92.97%136.56M | 92.97%136.56M |
| Cash at the end | --29.28M | -1.04%6.5M | -38.56%6.57M | --10.69M | -24.34%12.7M | -50.62%17.45M | -81.08%16.79M | -70.51%35.35M | -35.02%88.74M | 512.07%119.88M |
| Cash balance analysis | ||||||||||
| Cash and bank balance | ---- | ---- | ---- | ---- | -47.59%12.72M | ---- | --24.28M | ---- | ---- | ---- |
| Cash and cash equivalent balance | ---- | ---- | ---- | ---- | -47.59%12.72M | ---- | --24.28M | ---- | ---- | ---- |
| Currency Unit | MYR | MYR | MYR | MYR | MYR | MYR | MYR | MYR | MYR | MYR |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- |
| Auditor | Dahua Ma Shiyun Certified Public Accountants Co., Ltd. | Dahua Ma Shiyun Certified Public Accountants Co., Ltd. | Dahua Ma Shiyun Certified Public Accountants Co., Ltd. | Dahua Ma Shiyun Certified Public Accountants Co., Ltd. | Zhonghui Anda Certified Public Accountants Co., Ltd. | -- | Deloitte PLT | -- | Deloitte PLT | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.